

The UK is pioneering a unique National Cancer Vaccine Advance. This groundbreaking strategy could transform the outcomes of patients with cancer. It involves placing 10,000 patients through clinical trials by 2030. Doctors will utilise mRNA technology used to make coronavirus vaccines and use the technology to trial in cancer patients. If achieved, it will bring the UK back into the global vaccine main stage. These advances made by our country are potentially of historical level achievement, and the most tangible silver lining of our experiences in recent years.
The Great National Cancer Vaccine Summit will showcase the incredible progress and achievements around the country. We know that the most brilliant people have been working very hard in our best cancer centres, within the most agile organisations to give this advance a chance of success. The conference aims to foster a collaborative environment that encourages the exchange of knowledge, best practices, and innovative approaches to help people affected by cancer.
With attendees from industry, government, public sector, academia, research system and of course healthcare, together we will delve into the intricacies of this incredible national cancer vaccine advance that has captured the public imagination. The Great National Cancer Vaccine Summit seeks to underscore the global implications, paving the way for international collaborations and partnerships aimed at redefining the future of cancer care on a global scale.
Key Challenges:
Potential Outcomes:
As we celebrate the first year into this significant leap into the future with cancer vaccines, the NHS extends a heartfelt invitation to all oncology specialists and senior leaders to join us at this pivotal conference.
Embrace the opportunity to be at the forefront of groundbreaking advancements in immunotherapy and contribute to shaping the future of cancer care on a global scale.
Registration is free for all NHS oncology specialists, NHS staff, and public sector senior leaders and teams, so secure your place today and be a part of this momentous event that is set to shape the future of cancer treatment.
Registration and Breakfast
Registration and Breakfast
Chair Opening Address (Confirmed)
Chair Opening Address (Confirmed)
Keynote Presentation - Dame Kate Bingham, Board Member, The Francis Crick Institute (Provisonally Confirmed)
Keynote Presentation - Dame Kate Bingham, Board Member, The Francis Crick Institute (Provisonally Confirmed)
Keynote Presentation - Peter Johnson, Peter Johnstone, Vice Chair at Moffitt Cancer Center (Invited)
Keynote Presentation - Peter Johnson, Peter Johnstone, Vice Chair at Moffitt Cancer Center (Invited)
Keynote Presentation - Stefan Symeonides, Senior Clinical Lecturer in Medical Oncology, University of Edinburgh (Provisonally Confirmed)
Keynote Presentation - Stefan Symeonides, Senior Clinical Lecturer in Medical Oncology, University of Edinburgh (Provisonally Confirmed)
Keynote Presentation - Dr. Heather Shaw, Consultant Medical Oncologist, UCL (Provisonally Confirmed)
Keynote Presentation - Dr. Heather Shaw, Consultant Medical Oncologist, UCL (Provisonally Confirmed)
Keynote Presentation - Professor Gary Middleton, Institute of Immunology and Immunotherapy, Professor of Medical Oncology (Invited)
Keynote Presentation - Professor Gary Middleton, Institute of Immunology and Immunotherapy, Professor of Medical Oncology (Invited)
Q&A Panel
Q&A Panel
Morning Break
Morning Break
Chair Morning Reflection (Confirmed)
Chair Morning Reflection (Confirmed)
Case Study
Case Study
Case Study
Case Study
Keynote Presentation - Professor Christian Ottensmeier (Confirmed)
With decades of experience investigating immune responses, Professor Ottesnmeier will share an overview of the successes and challenges leading us to where we are now in cancer vaccine immunology. As a chief investigator on UK vaccine trials and top recruiter in multiple settings, he will share clinical experiences of cancer vaccine trials and explore the path onwards in the national vaccine advance.
Case Study
Case Study
Q&A Panel
Q&A Panel
Networking & Lunch
Networking & Lunch
Chair Afternoon Address (Confirmed)
Chair Afternoon Address (Confirmed)
Case Study
Case Study
Keynote Presentation - Professor Mererid Evans, Director of Wales Cancer Research Centre (Invited)
Keynote Presentation - Professor Mererid Evans, Director of Wales Cancer Research Centre (Invited)
Guest Speaker Session
Guest Speaker Session
Dr Pippa Corrie, Consultant Medical Oncologist, Addenbroke's Hospital (Provisionally Confirmed)
Professor Sarah Danson, Clinical Medicine, School of Medicine and Population Health, School Director of Research, Professor of Medical Oncology (Provisionally Confirmed)
Panel with Q&A
Panel with Q&A
Louise Medley, Consultant in Medical Oncology at Torbay and South Devon NHS Foundation Trust (Provisionally Confirmed)
Nangi Lo, Consultant Medical Oncologist at South Devon Healthcare NHS Foundation Trust (Provisionally Confirmed)
Panel with Q&A
Panel with Q&A
Jamie Blundell, Research Group Leader, CRUK Cambridge Centre Early Detection Programme (Invited)
Tim Elliott, Kidani Professor of Immuno-Oncology, Co-Director, Cancer Research UK Oxford Center (Invited)
Hot Buffet Food, Drinks and Networking
Hot Buffet Food, Drinks and Networking
End of Day
End of Day
To apply for a free ticket please select one of the options below.
Apply for FREE NHS Tickets Here
Apply for FREE Public Sector Tickets Here